Brain tumor pathology

Keyphrases

Publications

2024

Naohide Fujita, Andrew Bondoc, Sergio Simoes, Joji Ishida, Michael S Taccone, Amanda Luck, Dilakshan Srikanthan, Robert Siddaway, Adrian Levine, Nesrin Sabha, Stacey Krumholtz, Akihide Kondo, Hajime Arai, Christian Smith, Paul McDonald, Cynthia Hawkins, Shoukat Dedhar, James T Rutka
Combination treatment with histone deacetylase and carbonic anhydrase 9 inhibitors shows therapeutic potential in experimental diffuse intrinsic pontine glioma. Brain tumor pathology (2024)
Hirotaka Tsukamoto, Ryu Saito, Takahiro Shirakura, Takuma Nakashima, Ryo Yamamoto, Hirofumi Kazama, Mitsuto Hanihara, Hiromichi Suzuki, Sumihito Nobusawa, Hiroyuki Kinouchi
Astroblastoma with MN1::BEND2 in an elderly patient: A case report and review of the literature. Brain tumor pathology (2024)
Takuma Nakashima, Ryo Yamamoto, Makoto Ohno, Hirokazu Sugino, Masamichi Takahashi, Yusuke Funakoshi, Shohei Nambu, Atsuhito Uneda, Shunsuke Yanagisawa, Takeo Uzuka, Yoshiki Arakawa, Ryosuke Hanaya, Joji Ishida, Koji Yoshimoto, Ryuta Saito, Yoshitaka Narita, Hiromichi Suzuki
Development of a rapid and comprehensive genomic profiling test supporting diagnosis and research for gliomas. Brain tumor pathology (2024)
Fumi Higuchi, Takeo Uzuka, Hadzki Matsuda, Takuma Sumi, Kayoko Iwata, Takashi Namatame, Masahiro Shin, Hiroyoshi Akutsu, Keisuke Ueki
Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment. Brain tumor pathology (2024)
Koki Onodera, Mitsuaki Shirahata, Reina Mizuno, Masayoshi Fukuoka, Tomonari Suzuki, Tsugumi Satoh, Taku Homma, Naoki Takahashi, Kazuhiko Mishima
Double-hit primary central nervous system lymphoma with histogenetically proven bone marrow infiltration: a case report and a review of the literature. Brain tumor pathology (2024)
Hirohisa Yajima, Shunsaku Takayanagi, Hirokazu Takami, Shota Tanaka, Masashi Nomura, Kaishi Satomi, Masako Ikemura, Sumihito Nobusawa, Ryuta Saito, Akihide Kondo, Nobuhito Saito
Novel case of ependymoma-like tumor with mesenchymal differentiation harboring ZFTA::RELA fusion in an adult. Brain tumor pathology (2024)
Jun Takei, Miku Maeda, Nei Fukasawa, Masaharu Kawashima, Misayo Miyake, Kyoichi Tomoto, Shohei Nawate, Akihiko Teshigawara, Tomoya Suzuki, Yohei Yamamoto, Hiroyasu Nagashima, Ryosuke Mori, Ryoko Fukushima, Satoshi Matsushima, Hiroyoshi Kino, Ai Muroi, Takao Tsurubuchi, Noriaki Sakamoto, Kaichi Nishiwaki, Shingo Yano, Yuzuru Hasegawa, Yuichi Murayama, Yasuharu Akasaki, Masayuki Shimoda, Eiichi Ishikawa, Toshihide Tanaka
Comparative analyses of immune cells and alpha-smooth muscle actin-positive cells under the immunological microenvironment between with and without dense fibrosis in primary central nervous system lymphoma. Brain tumor pathology (2024)
Shilpa Rao, Aditi Goyal, Allen Johnson, Nishanth Sadashiva, Karthik Kulanthaivelu, Vikas Vazhayil, Vani Santosh
MAPK pathway alterations in polymorphous low-grade neuroepithelial tumor of the young: diagnostic considerations. Brain tumor pathology (2024)
Motoo Nagane
Preface for Brain Tumor Pathology vol.41 issue 2 : (Special issue for the 41st Annual Meeting of the Japan Society of Brain Tumor Pathology). Brain tumor pathology (2024)
Taketo Ezaki, Toshihide Tanaka, Ryota Tamura, Kentaro Ohara, Yohei Yamamoto, Jun Takei, Yukina Morimoto, Ryotaro Imai, Yuki Kuranari, Yasuharu Akasaki, Masahiro Toda, Yuichi Murayama, Keisuke Miyake, Hikaru Sasaki
Correction: Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment. Brain tumor pathology (2024)
Taketo Ezaki, Toshihide Tanaka, Ryota Tamura, Kentaro Ohara, Yohei Yamamoto, Jun Takei, Yukina Morimoto, Ryotaro Imai, Yuki Kuranai, Yasuharu Akasaki, Masahiro Toda, Yuichi Murayama, Keisuke Miyake, Hikaru Sasaki
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment. Brain tumor pathology (2024)
Kenta Masui, Hiromi Onizuka, Yoshihiro Muragaki, Takakazu Kawamata, Atsushi Kurata, Takashi Komori
Intratumoral heterogeneity of CDKN2A deletions in IDH-mutant astrocytoma. Brain tumor pathology (2024)
Manabu Natsumeda, Satoshi Shibuma, Haruhiko Takahashi, Jotaro On, Yoshihiro Mouri, Kaoru Tomikawa, Hidemoto Fujiwara, Jun Watanabe, Yoshihiro Tsukamoto, Masayasu Okada, Rui Takeda, Hiroshi Shimizu, Jun Takizawa, Akiyoshi Kakita, Makoto Oishi
Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature. Brain tumor pathology (2024)
Takahiro Tsuchiya, Masako Ikemura, Satoru Miyawaki, Yu Teranishi, Kenta Ohara, Tetsuo Ushiku, Nobuhito Saito
Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis. Brain tumor pathology (2024)
Maki Sakaguchi, Masafumi Horie, Yukinobu Ito, Shingo Tanaka, Keishi Mizuguchi, Hiroko Ikeda, Etsuko Kiyokawa, Mitsutoshi Nakada, Daichi Maeda
Comprehensive genomic analysis reveals clonal origin and subtype-specific evolution in a case of sporadic multiple meningiomas. Brain tumor pathology (2024)
Hikaru Sasaki, Yohei Kitamura, Masahiro Toda, Yuichi Hirose, Kazunari Yoshida
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy. Brain tumor pathology (2024)
Takashi Komori
Correction: Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next. Brain tumor pathology (2024)

volume 41, number 1, 2024

Takashi Komori
Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next. Brain tumor pathology 41 (1) (2024)
Takashi Komori
Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next. Brain tumor pathology 41 (1) (2024)

volume 41, number 2, 2024

Kenta Masui, Hiromi Onizuka, Yoshihiro Muragaki, Takakazu Kawamata, Atsushi Kurata, Takashi Komori
Intratumoral heterogeneity of CDKN2A deletions in IDH-mutant astrocytoma. Brain tumor pathology 41 (2) (2024)
Taketo Ezaki, Toshihide Tanaka, Ryota Tamura, Kentaro Ohara, Yohei Yamamoto, Jun Takei, Yukina Morimoto, Ryotaro Imai, Yuki Kuranai, Yasuharu Akasaki, Masahiro Toda, Yuichi Murayama, Keisuke Miyake, Hikaru Sasaki
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment. Brain tumor pathology 41 (2) (2024)
Taketo Ezaki, Toshihide Tanaka, Ryota Tamura, Kentaro Ohara, Yohei Yamamoto, Jun Takei, Yukina Morimoto, Ryotaro Imai, Yuki Kuranai, Yasuharu Akasaki, Masahiro Toda, Yuichi Murayama, Keisuke Miyake, Hikaru Sasaki
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment. Brain tumor pathology 41 (2) (2024)
Takahiro Tsuchiya, Masako Ikemura, Satoru Miyawaki, Yu Teranishi, Kenta Ohara, Tetsuo Ushiku, Nobuhito Saito
Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis. Brain tumor pathology 41 (2) (2024)
Taketo Ezaki, Toshihide Tanaka, Ryota Tamura, Kentaro Ohara, Yohei Yamamoto, Jun Takei, Yukina Morimoto, Ryotaro Imai, Yuki Kuranai, Yasuharu Akasaki, Masahiro Toda, Yuichi Murayama, Keisuke Miyake, Hikaru Sasaki
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment. Brain tumor pathology 41 (2) (2024)
Manabu Natsumeda, Satoshi Shibuma, Haruhiko Takahashi, Jotaro On, Yoshihiro Mouri, Kaoru Tomikawa, Hidemoto Fujiwara, Jun Watanabe, Yoshihiro Tsukamoto, Masayasu Okada, Rui Takeda, Hiroshi Shimizu, Jun Takizawa, Akiyoshi Kakita, Makoto Oishi
Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature. Brain tumor pathology 41 (2) (2024)
Taketo Ezaki, Toshihide Tanaka, Ryota Tamura, Kentaro Ohara, Yohei Yamamoto, Jun Takei, Yukina Morimoto, Ryotaro Imai, Yuki Kuranai, Yasuharu Akasaki, Masahiro Toda, Yuichi Murayama, Keisuke Miyake, Hikaru Sasaki
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment. Brain tumor pathology 41 (2) (2024)
Fumi Higuchi, Takeo Uzuka, Hadzki Matsuda, Takuma Sumi, Kayoko Iwata, Takashi Namatame, Masahiro Shin, Hiroyoshi Akutsu, Keisuke Ueki
Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment. Brain tumor pathology 41 (2) (2024)
Hikaru Sasaki, Yohei Kitamura, Masahiro Toda, Yuichi Hirose, Kazunari Yoshida
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy. Brain tumor pathology 41 (2) (2024)
Takahiro Tsuchiya, Masako Ikemura, Satoru Miyawaki, Yu Teranishi, Kenta Ohara, Tetsuo Ushiku, Nobuhito Saito
Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis. Brain tumor pathology 41 (2) (2024)
Kenta Masui, Hiromi Onizuka, Yoshihiro Muragaki, Takakazu Kawamata, Atsushi Kurata, Takashi Komori
Intratumoral heterogeneity of CDKN2A deletions in IDH-mutant astrocytoma. Brain tumor pathology 41 (2) (2024)
Manabu Natsumeda, Satoshi Shibuma, Haruhiko Takahashi, Jotaro On, Yoshihiro Mouri, Kaoru Tomikawa, Hidemoto Fujiwara, Jun Watanabe, Yoshihiro Tsukamoto, Masayasu Okada, Rui Takeda, Hiroshi Shimizu, Jun Takizawa, Akiyoshi Kakita, Makoto Oishi
Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature. Brain tumor pathology 41 (2) (2024)
Hikaru Sasaki, Yohei Kitamura, Masahiro Toda, Yuichi Hirose, Kazunari Yoshida
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy. Brain tumor pathology 41 (2) (2024)
Takuma Nakashima, Ryo Yamamoto, Makoto Ohno, Hirokazu Sugino, Masamichi Takahashi, Yusuke Funakoshi, Shohei Nambu, Atsuhito Uneda, Shunsuke Yanagisawa, Takeo Uzuka, Yoshiki Arakawa, Ryosuke Hanaya, Joji Ishida, Koji Yoshimoto, Ryuta Saito, Yoshitaka Narita, Hiromichi Suzuki
Development of a rapid and comprehensive genomic profiling test supporting diagnosis and research for gliomas. Brain tumor pathology 41 (2) (2024)
Taketo Ezaki, Toshihide Tanaka, Ryota Tamura, Kentaro Ohara, Yohei Yamamoto, Jun Takei, Yukina Morimoto, Ryotaro Imai, Yuki Kuranai, Yasuharu Akasaki, Masahiro Toda, Yuichi Murayama, Keisuke Miyake, Hikaru Sasaki
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment. Brain tumor pathology 41 (2) (2024)
Takahiro Tsuchiya, Masako Ikemura, Satoru Miyawaki, Yu Teranishi, Kenta Ohara, Tetsuo Ushiku, Nobuhito Saito
Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis. Brain tumor pathology 41 (2) (2024)
Motoo Nagane
Preface for Brain Tumor Pathology vol.41 issue 2 : (Special issue for the 41st Annual Meeting of the Japan Society of Brain Tumor Pathology). Brain tumor pathology 41 (2) (2024)
Motoo Nagane
Preface for Brain Tumor Pathology vol.41 issue 2 : (Special issue for the 41st Annual Meeting of the Japan Society of Brain Tumor Pathology). Brain tumor pathology 41 (2) (2024)
Kenta Masui, Hiromi Onizuka, Yoshihiro Muragaki, Takakazu Kawamata, Atsushi Kurata, Takashi Komori
Intratumoral heterogeneity of CDKN2A deletions in IDH-mutant astrocytoma. Brain tumor pathology 41 (2) (2024)
Fumi Higuchi, Takeo Uzuka, Hadzki Matsuda, Takuma Sumi, Kayoko Iwata, Takashi Namatame, Masahiro Shin, Hiroyoshi Akutsu, Keisuke Ueki
Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment. Brain tumor pathology 41 (2) (2024)
Takahiro Tsuchiya, Masako Ikemura, Satoru Miyawaki, Yu Teranishi, Kenta Ohara, Tetsuo Ushiku, Nobuhito Saito
Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis. Brain tumor pathology 41 (2) (2024)
Takahiro Tsuchiya, Masako Ikemura, Satoru Miyawaki, Yu Teranishi, Kenta Ohara, Tetsuo Ushiku, Nobuhito Saito
Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis. Brain tumor pathology 41 (2) (2024)
Fumi Higuchi, Takeo Uzuka, Hadzki Matsuda, Takuma Sumi, Kayoko Iwata, Takashi Namatame, Masahiro Shin, Hiroyoshi Akutsu, Keisuke Ueki
Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment. Brain tumor pathology 41 (2) (2024)
Manabu Natsumeda, Satoshi Shibuma, Haruhiko Takahashi, Jotaro On, Yoshihiro Mouri, Kaoru Tomikawa, Hidemoto Fujiwara, Jun Watanabe, Yoshihiro Tsukamoto, Masayasu Okada, Rui Takeda, Hiroshi Shimizu, Jun Takizawa, Akiyoshi Kakita, Makoto Oishi
Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature. Brain tumor pathology 41 (2) (2024)
Taketo Ezaki, Toshihide Tanaka, Ryota Tamura, Kentaro Ohara, Yohei Yamamoto, Jun Takei, Yukina Morimoto, Ryotaro Imai, Yuki Kuranai, Yasuharu Akasaki, Masahiro Toda, Yuichi Murayama, Keisuke Miyake, Hikaru Sasaki
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment. Brain tumor pathology 41 (2) (2024)
Takuma Nakashima, Ryo Yamamoto, Makoto Ohno, Hirokazu Sugino, Masamichi Takahashi, Yusuke Funakoshi, Shohei Nambu, Atsuhito Uneda, Shunsuke Yanagisawa, Takeo Uzuka, Yoshiki Arakawa, Ryosuke Hanaya, Joji Ishida, Koji Yoshimoto, Ryuta Saito, Yoshitaka Narita, Hiromichi Suzuki
Development of a rapid and comprehensive genomic profiling test supporting diagnosis and research for gliomas. Brain tumor pathology 41 (2) (2024)
Hikaru Sasaki, Yohei Kitamura, Masahiro Toda, Yuichi Hirose, Kazunari Yoshida
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy. Brain tumor pathology 41 (2) (2024)

volume 41, number 1, 2023

Luyi Zhang, Gang Zhang, Han Zheng, Bin Jiang, Yongzhi Ju, Qianqian Duan, Lu An, Hangyu Shi
A rare case of primary central nervous system histiocytic sarcoma harboring a novel ARHGAP45::BRAF fusion: a case report and literature review. Brain tumor pathology 41 (1) (2023)
Satoshi Nakata, Yasuhito Arai, Kohei Fukuoka, Takahiro Shirakura, Ayako Yamazaki, Sho Osawa, Natsuko Hama, Tatsuhiro Shibata, Takaaki Miyagishima, Keishi Horiguchi, Masahiko Tosaka, Hideaki Yokoo, Yuhei Yoshimoto, Sumihito Nobusawa
Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation. Brain tumor pathology 41 (1) (2023)
Sofian Al Shboul, Shelagh Boyle, Ashita Singh, Tareq Saleh, Moath Alrjoub, Ola Abu Al Karsaneh, Amel Mryyian, Rand Dawoud, Sinem Gul, Shaden Abu Baker, Kathryn Ball, Ted Hupp, Paul M Brennan
FISH analysis reveals CDKN2A and IFNA14 co-deletion is heterogeneous and is a prominent feature of glioblastoma. Brain tumor pathology 41 (1) (2023)
Satoshi Nakata, Yasuhito Arai, Kohei Fukuoka, Takahiro Shirakura, Ayako Yamazaki, Sho Osawa, Natsuko Hama, Tatsuhiro Shibata, Takaaki Miyagishima, Keishi Horiguchi, Masahiko Tosaka, Hideaki Yokoo, Yuhei Yoshimoto, Sumihito Nobusawa
Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation. Brain tumor pathology 41 (1) (2023)